Home/Filings/4/0001615219-21-000087
4//SEC Filing

Arthur David J. 4

Accession 0001615219-21-000087

CIK 0001615219other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 4:08 PM ET

Size

6.5 KB

Accession

0001615219-21-000087

Insider Transaction Report

Form 4
Period: 2021-08-17
Arthur David J.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-08-17$0.90/sh+2,000$1,798100,247 total(indirect: By daughter)
  • Purchase

    Common Stock

    2021-08-17$0.89/sh+2,000$1,784102,247 total(indirect: By son)
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001769331

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:08 PM ET
Size
6.5 KB